Safety of Bevacizumab Treatment in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Full-Dose Anticoagulation (FDAC) Treated on Protocol BO17704
Title:
Safety of Bevacizumab Treatment in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Full-Dose Anticoagulation (FDAC) Treated on Protocol BO17704
Author:
Skillings, J. LaFleur, F. Leighl, N. Bennouna, J. Kuo, H.-P. Szima, B. Gottfried, M. Kunitsyn, A. Trigo, J.M. Chang, G.-C. Cosaert, J. Manegold, C.